Every story is better with a villain. In the eyes of the federal government, the behavioral health treatment industry’s villain is private equity. At least, that’s the impression of lenders and private equity investors. Despite this view, lenders and PE believe that increased scrutiny on private equity from the Federal Trade Commission and the Department […]
Capital One
The current financial climate may mean fewer mega deals in behavioral health next year. But investors will likely continue to have a healthy appetite for smaller transactions, industry insiders believe. “I think that buyers will get more selective, but I think the demand is still [there],” Kevin Taggart, managing partner at Mertz Taggart, said during […]